Nefazodone and CYP450 3A4 interactions with cyclosporine and tacrolimus [2]

Transplantation

Volumn 74, Issue 5, 2002, Pages 745-

  Garton, Theresa ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; CYTOCHROME P450 3A4; FLUOXETINE; NEFAZODONE; PAROXETINE; SERTRALINE; TACROLIMUS; TRAZODONE;

ABDOMINAL PAIN; AGITATION; ALCOHOL LIVER CIRRHOSIS; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; DRUG WITHDRAWAL; GRAFT REJECTION; HEPATITIS C; HUMAN; LETTER; LIVER BIOPSY; LIVER CELL DAMAGE; LIVER FUNCTION; LIVER TRANSPLANTATION; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; SEDATION; SEXUAL DYSFUNCTION; SIDE EFFECT; TREATMENT OUTCOME;

EID: 0037106486     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200209150-00028     Document Type: Letter

References (5)

1. Aranda-Michel J, Koehler A, Bejarano PA, et al. Nefazodone-induced liver failure: report of three cases. Ann Intern Med 1999;130:285.
2. Schrader GD, Roberts-Thompson JC. Adverse effect of nefazodone: hepatitis. Med J Aust 1999;170:452.
3. Gelenberg A. Liver failure with nefazodone. Biol Ther Psychiatr 1999;22:34.
4. Ellouk-Achard S, Martin C, Duc HT, et al. FK506 (tacrolimus) decreases the cytotoxicity of cyclosporin A in rat hepatocytes in primary culture: implication of CYP3A induction. Arch Toxicol 1998;72:257.
5. Stahl, Stephen M. Essential psychopharmacology: Neuroscientific basis and practical applications. Cambridge University Press 2000, pp 256-262.